77
Views
18
CrossRef citations to date
0
Altmetric
Review

Targeting the proteasome in mantle cell lymphoma: A promising therapeutic approach

, & , MD
Pages 195-205 | Received 19 Apr 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Danyu Sun & Mitchell R Smith. (2014) Bortezomib for the treatment of mantle cell lymphoma. Expert Opinion on Orphan Drugs 2:11, pages 1233-1241.
Read now
Annie Fourrier-Réglat, Pernelle Noize, Thierry Facon, Jean-Paul Fermand, Olivier Fitoussi, Gérald Marit, Patrick Thomaré, Philip Robinson, Emmanuelle Bignon, Jérémy Jové, Régis Lassalle, Magali Rouyer, Angela Grelaud & Nicholas Moore. (2014) Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study. Leukemia & Lymphoma 55:4, pages 848-854.
Read now
André Goy, Steven H. Bernstein, Alice Mcdonald, Michael D. Pickard, Hongliang Shi, Mark D. Fleming, Barb Bryant, William Trepicchio, Richard I. Fisher, Anthony L. Boral & George Mulligan. (2010) Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial. Leukemia & Lymphoma 51:7, pages 1269-1277.
Read now
Jan Sterz, Ivana von Metzler, Jens-Claus Hahne, Britta Lamottke, Jessica Rademacher, Ulrike Heider, Evangelos Terpos & Orhan Sezer. (2008) The potential of proteasome inhibitors in cancer therapy. Expert Opinion on Investigational Drugs 17:6, pages 879-895.
Read now

Articles from other publishers (13)

Brian G. Till. (2018) Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma. Current Treatment Options in Oncology 19:9.
Crossref
Brian G. Till, Hongli Li, Steven H. Bernstein, Richard I. Fisher, W. Richard Burack, Lisa M. Rimsza, Justin D. Floyd, Marco A. DaSilva, Dennis F. MooreJrJr, Olga Pozdnyakova, Sonali M. Smith, Michael LeBlanc & Jonathan W. Friedberg. (2016) Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601. British Journal of Haematology 172:2, pages 208-218.
Crossref
Amareshwar T.K. Singh, Andrew M. Evens, Reilly J. Anderson, Jennifer A. Beckstead, Natesan Sankar, Antonella Sassano, Savita Bhalla, Shuo Yang, Leonidas C. Platanias, Trudy M. Forte, Robert O. Ryan & Leo I. Gordon. (2010) All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. British Journal of Haematology, pages no-no.
Crossref
Marc Weinkauf, Yvonne Zimmermann, Elena Hartmann, Andreas Rosenwald, Malte Rieken, Alessandro Pastore, Grit Hutter, Wolfgang Hiddemann & Martin Dreyling. (2009) 2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma. ELECTROPHORESIS 30:6, pages 974-986.
Crossref
Elena M HartmannGerman OttAndreas Rosenwald. (2009) Molecular outcome prediction in mantle cell lymphoma. Future Oncology 5:1, pages 63-73.
Crossref
Bruce Ruggeri, Sheila Miknyoczki, Bruce Dorsey & Ai-Min Hui. 2009. Contemporary Aspects of Biomedical Research - Drug Discovery. Contemporary Aspects of Biomedical Research - Drug Discovery 91 135 .
Steffen Blenk, Julia C Engelmann, Stefan Pinkert, Markus Weniger, Jörg Schultz, Andreas Rosenwald, Hans K Müller-Hermelink, Tobias Müller & Thomas Dandekar. (2008) Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. BMC Cancer 8:1.
Crossref
Leonóra Méhes, Béla Telek, Miklós Udvardy, Ágota Schlammadinger & László Rejtő. (2008) Mantle cell lymphoma: case report. Orvosi Hetilap 149:31, pages 1471-1474.
Crossref
Laura Smith, Michael J. Lind, Philip J. Drew & Lynn Cawkwell. (2007) The putative roles of the ubiquitin/proteasome pathway in resistance to anticancer therapy. European Journal of Cancer 43:16, pages 2330-2338.
Crossref
Richard J. FordLong ShenYen Chiu Lin-LeeLan V. PhamAsha MultaniHai-Jun ZhouArchito T. TamayoChongJie ZhangLesleyann Hawthorn, John K. Cowell & Julian L. AmbrusJrJr. (2007) Development of a murine model for blastoid variant mantle-cell lymphoma. Blood 109:11, pages 4899-4906.
Crossref
Sophie Krieger, Juliette Gauduchon, Mikel Roussel, Xavier Troussard & Brigitte Sola. (2006) Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma. BMC Cancer 6:1.
Crossref
Richard I. FisherSteven H. BernsteinBrad S. KahlBenjamin DjulbegovicMichael J. RobertsonSven de VosElliot EpnerAmrita KrishnanJohn P. LeonardSagar LonialEdward A. StadtmauerOwen A. O'ConnorHongliang ShiAnthony L. BoralAndré Goy. (2006) Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma. Journal of Clinical Oncology 24:30, pages 4867-4874.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:2, pages 89-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.